Northern Trust
REGN icon

Northern Trust’s Regeneron Pharmaceuticals REGN Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$503M Sell
958,569
-43,181
-4% -$22.7M 0.07% 245
2025
Q1
$635M Sell
1,001,750
-53,079
-5% -$33.7M 0.09% 197
2024
Q4
$751M Buy
1,054,829
+136,184
+15% +$97M 0.11% 172
2024
Q3
$966M Sell
918,645
-48,081
-5% -$50.5M 0.16% 121
2024
Q2
$1.02B Sell
966,726
-24,739
-2% -$26M 0.17% 108
2024
Q1
$954M Sell
991,465
-54,943
-5% -$52.9M 0.16% 121
2023
Q4
$919M Sell
1,046,408
-20,802
-2% -$18.3M 0.17% 121
2023
Q3
$878M Buy
1,067,210
+34,326
+3% +$28.2M 0.17% 115
2023
Q2
$742M Sell
1,032,884
-121,689
-11% -$87.4M 0.14% 133
2023
Q1
$949M Sell
1,154,573
-9,439
-0.8% -$7.76M 0.19% 104
2022
Q4
$840M Sell
1,164,012
-24,785
-2% -$17.9M 0.18% 113
2022
Q3
$819M Sell
1,188,797
-10,365
-0.9% -$7.14M 0.19% 106
2022
Q2
$709M Sell
1,199,162
-1,952
-0.2% -$1.15M 0.15% 129
2022
Q1
$839M Sell
1,201,114
-2,212
-0.2% -$1.54M 0.15% 129
2021
Q4
$760M Buy
1,203,326
+3,291
+0.3% +$2.08M 0.12% 149
2021
Q3
$726M Buy
1,200,035
+38,532
+3% +$23.3M 0.13% 141
2021
Q2
$649M Sell
1,161,503
-15,589
-1% -$8.71M 0.11% 157
2021
Q1
$557M Sell
1,177,092
-65,883
-5% -$31.2M 0.1% 176
2020
Q4
$600M Sell
1,242,975
-43,727
-3% -$21.1M 0.12% 158
2020
Q3
$720M Buy
1,286,702
+61,531
+5% +$34.4M 0.16% 120
2020
Q2
$764M Buy
1,225,171
+264,126
+27% +$165M 0.18% 103
2020
Q1
$469M Buy
961,045
+14,449
+2% +$7.06M 0.13% 147
2019
Q4
$355M Buy
946,596
+4,771
+0.5% +$1.79M 0.08% 240
2019
Q3
$261M Sell
941,825
-36,693
-4% -$10.2M 0.06% 294
2019
Q2
$306M Buy
978,518
+5,530
+0.6% +$1.73M 0.07% 258
2019
Q1
$400M Buy
972,988
+20,218
+2% +$8.3M 0.1% 202
2018
Q4
$356M Buy
952,770
+22,468
+2% +$8.39M 0.1% 196
2018
Q3
$376M Sell
930,302
-3,943
-0.4% -$1.59M 0.09% 212
2018
Q2
$322M Buy
934,245
+17,931
+2% +$6.19M 0.08% 234
2018
Q1
$316M Sell
916,314
-18,895
-2% -$6.51M 0.08% 245
2017
Q4
$352M Sell
935,209
-22,751
-2% -$8.55M 0.09% 226
2017
Q3
$428M Buy
957,960
+26,677
+3% +$11.9M 0.11% 184
2017
Q2
$457M Buy
931,283
+6,977
+0.8% +$3.43M 0.13% 156
2017
Q1
$358M Buy
924,306
+29,484
+3% +$11.4M 0.1% 193
2016
Q4
$328M Sell
894,822
-28,866
-3% -$10.6M 0.1% 199
2016
Q3
$371M Buy
923,688
+157
+0% +$63.1K 0.12% 177
2016
Q2
$323M Sell
923,531
-105
-0% -$36.7K 0.1% 196
2016
Q1
$338M Sell
923,636
-3,248
-0.4% -$1.19M 0.11% 182
2015
Q4
$503M Sell
926,884
-37,488
-4% -$20.4M 0.17% 114
2015
Q3
$449M Sell
964,372
-26,046
-3% -$12.1M 0.15% 132
2015
Q2
$505M Buy
990,418
+64,211
+7% +$32.8M 0.15% 134
2015
Q1
$418M Sell
926,207
-25,358
-3% -$11.4M 0.13% 165
2014
Q4
$390M Sell
951,565
-9,573
-1% -$3.93M 0.12% 174
2014
Q3
$347M Sell
961,138
-58,548
-6% -$21.1M 0.11% 177
2014
Q2
$288M Sell
1,019,686
-43,055
-4% -$12.2M 0.09% 215
2014
Q1
$319M Buy
1,062,741
+17,417
+2% +$5.23M 0.1% 192
2013
Q4
$288M Buy
1,045,324
+40,607
+4% +$11.2M 0.09% 209
2013
Q3
$314M Sell
1,004,717
-10,501
-1% -$3.29M 0.11% 180
2013
Q2
$228M Buy
+1,015,218
New +$228M 0.08% 235